• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 211/30 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom

Patent holdings for IPC class C07D 211/30

Total number of patents in this class: 53

10-year publication summary

2
2
1
2
3
1
0
0
1
0
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Theravance Biopharma R&D IP, LLC
516
6
Prilenia Neurotherapeutics Ltd.
88
4
Merck Patent GmbH
5873
3
Ecolab USA Inc.
5392
3
F. Hoffmann-La Roche AG
7972
2
Genentech, Inc.
3897
2
AstraZeneca AB
2963
2
Constellation Pharmaceuticals, Inc.
210
2
Nagoya Industrial Science Research Institute
27
2
Nippon Zoki Pharmaceutical Co., Ltd.
149
2
Merck Sharp & Dohme LLC
3758
2
BASF SE
20565
1
The Regents of the University of California
19630
1
Janssen Pharmaceutica N.V.
3589
1
Syngenta Crop Protection AG
5246
1
The Board of Trustees of the Leland Stanford Junior University
6287
1
Takeda Pharmaceutical Company Limited
2938
1
The Chancellor, Masters and Scholars of The University of Oxford
159
1
Genzyme Corporation
1219
1
Global Blood Therapeutics, Inc.
182
1
Other owners 14